La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Autobio Diagnostics Croissance future
Future contrôle des critères 2/6
Autobio Diagnostics is forecast to grow earnings and revenue by 19.6% and 16.3% per annum respectively. EPS is expected to grow by 19.3% per annum. Return on equity is forecast to be 17.1% in 3 years.
Informations clés
19.6%
Taux de croissance des bénéfices
19.3%
Taux de croissance du BPA
Medical Equipment croissance des bénéfices | 22.5% |
Taux de croissance des recettes | 16.3% |
Rendement futur des capitaux propres | 17.1% |
Couverture par les analystes | Good |
Dernière mise à jour | 20 Aug 2024 |
Mises à jour récentes de la croissance future
Recent updates
Autobio Diagnostics Co., Ltd. (SHSE:603658) Shares Could Be 35% Above Their Intrinsic Value Estimate
Aug 09Improved Earnings Required Before Autobio Diagnostics Co., Ltd. (SHSE:603658) Shares Find Their Feet
Jul 18Does Autobio Diagnostics (SHSE:603658) Have A Healthy Balance Sheet?
May 21Autobio Diagnostics Co., Ltd.'s (SHSE:603658) 27% Price Boost Is Out Of Tune With Earnings
Feb 27Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2026 | 7,029 | 2,238 | N/A | 2,396 | 8 |
12/31/2025 | 6,091 | 1,846 | N/A | 2,080 | 11 |
12/31/2024 | 5,131 | 1,518 | N/A | 1,638 | 10 |
3/31/2024 | 4,496 | 1,300 | 686 | 1,595 | N/A |
12/31/2023 | 4,444 | 1,217 | 569 | 1,470 | N/A |
9/30/2023 | 4,403 | 1,169 | 609 | 1,501 | N/A |
6/30/2023 | 4,479 | 1,180 | 656 | 1,525 | N/A |
3/31/2023 | 4,447 | 1,169 | 631 | 1,580 | N/A |
12/31/2022 | 4,442 | 1,167 | 620 | 1,558 | N/A |
9/30/2022 | 4,352 | 1,156 | 581 | 1,536 | N/A |
6/30/2022 | 4,159 | 1,095 | 508 | 1,508 | N/A |
3/31/2022 | 3,980 | 1,042 | 386 | 1,384 | N/A |
12/31/2021 | 3,766 | 974 | 395 | 1,461 | N/A |
9/30/2021 | 3,626 | 950 | 467 | 1,608 | N/A |
6/30/2021 | 3,450 | 887 | 125 | 1,339 | N/A |
3/31/2021 | 3,245 | 826 | -23 | 1,191 | N/A |
12/31/2020 | 2,978 | 748 | -121 | 995 | N/A |
9/30/2020 | 2,833 | 751 | -361 | 630 | N/A |
6/30/2020 | 2,706 | 728 | -202 | 717 | N/A |
3/31/2020 | 2,682 | 746 | -35 | 797 | N/A |
12/31/2019 | 2,679 | 774 | 81 | 843 | N/A |
9/30/2019 | 2,463 | 689 | 44 | 754 | N/A |
6/30/2019 | 2,261 | 636 | 142 | 685 | N/A |
3/31/2019 | 2,062 | 588 | 216 | 650 | N/A |
12/31/2018 | 1,930 | 563 | 244 | 654 | N/A |
9/30/2018 | 1,777 | 534 | 215 | 566 | N/A |
6/30/2018 | 1,666 | 502 | 193 | 537 | N/A |
3/31/2018 | 1,574 | 475 | 167 | 507 | N/A |
12/31/2017 | 1,400 | 447 | N/A | 482 | N/A |
9/30/2017 | 1,271 | 419 | N/A | 501 | N/A |
6/30/2017 | 1,129 | 393 | N/A | 461 | N/A |
3/31/2017 | 1,030 | 363 | N/A | 444 | N/A |
12/31/2016 | 980 | 350 | N/A | 416 | N/A |
9/30/2016 | 898 | 335 | N/A | 360 | N/A |
6/30/2016 | 837 | 317 | N/A | 371 | N/A |
3/31/2016 | 752 | 278 | N/A | 313 | N/A |
12/31/2015 | 716 | 278 | N/A | 309 | N/A |
12/31/2014 | 563 | 208 | N/A | 257 | N/A |
12/31/2013 | 409 | 124 | N/A | 103 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: 603658's forecast earnings growth (19.6% per year) is above the savings rate (2.9%).
Bénéfices vs marché: 603658's earnings (19.6% per year) are forecast to grow slower than the CN market (21.9% per year).
Croissance élevée des bénéfices: 603658's earnings are forecast to grow, but not significantly.
Chiffre d'affaires vs marché: 603658's revenue (16.3% per year) is forecast to grow faster than the CN market (13.4% per year).
Croissance élevée des revenus: 603658's revenue (16.3% per year) is forecast to grow slower than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: 603658's Return on Equity is forecast to be low in 3 years time (17.1%).